Papers
1
Total Citations
15
H-Index
1
About
Yanyan Li is an innovative biomedical researcher specializing in the intersection of bioprinting technology, cancer biology, and disease modeling. Her pioneering work focuses on recreating complex physiological microenvironments *in vitro*, with particular emphasis on hematological malignancies. Most notably, Li has made significant strides in developing three-dimensional bone marrow niche models for studying acute myeloid leukemia (AML), a notoriously difficult-to-treat blood cancer characterized by high relapse rates. Her landmark 2023 study introduced an automated, robotic multicellular bioprinting system capable of fabricating sophisticated AML disease models that faithfully recapitulate the bone marrow microenvironment — a critical advancement for understanding drug resistance mechanisms and identifying novel therapeutic targets. This work, already accumulating 15 citations within its first year of publication, underscores the growing recognition of her contributions to preclinical cancer research. By bridging advanced manufacturing technologies with oncology research, Li's work holds transformative potential for accelerating drug discovery and improving outcomes for AML patients. Her research represents a compelling example of how engineering-driven approaches can fundamentally reshape our understanding of cancer biology and therapeutic development.
Research Focus
Key Achievements
Top Papers
- 1